Sponsor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Clinical research sponsor

Published trials57
Recruiting shown6
Roles2
SourceClinicalTrials.gov

Clinical trials

57 shown
Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 DiabetesNCT07835360 · lead sponsor · 2026-07-10
RECRUITING
REgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases (RECONNECTIVE)NCT05665556 · lead sponsor · 2022-12-15
RECRUITING
Metformin Effects According to SLC16A11 Carrier StatusNCT07760883 · lead sponsor · 2020-09-23
RECRUITING
Validation of an Integrated Attention Model for Patients With Type 2 DiabetesNCT02836808 · lead sponsor · 2013-10-31
RECRUITING
Effect of Oral Calcium Butyrate Supplementation in ObesityNCT07583017 · lead sponsor · 2026-08-01
NOT_YET_RECRUITING
Effect of an Intervention With Apple Cider Vinegar on Glycemic Variability and Lipid Profile in Patients With Type 2 Diabetes MellitusNCT07493707 · lead sponsor · 2024-05-06
ACTIVE_NOT_RECRUITING
Effect of Weight Loss on Hepcidin Levels and Iron Status in Subjects With Obesity.NCT06104800 · lead sponsor · 2024-01-08
COMPLETED
Chrono Nutrition and Insulin Resistance in DiabetesNCT06163248 · lead sponsor · 2024-01-01
UNKNOWN
Comparison Between Endogenous and Exogenous Ketosis in Patients With Non-ischemic Chronic Heart Failure With Reduced Ejection FractionNCT04921293 · lead sponsor · 2023-06-01
UNKNOWN
Metabolic Impact on the Mitochondria-gut Microbiota Axis of Failure to Follow Restrictive Dietary Interventions in Subjects Living With ObesityNCT06782009 · lead sponsor · 2023-04-08
COMPLETED
Personalized Nutrition Based on the Glycemic Response: Effect of Diet and Intestinal MicrobiotaNCT05230342 · lead sponsor · 2022-08-02
ACTIVE_NOT_RECRUITING
Effect of Dietary Restrictions and Ketogenic Diet on Mitochondrial Function and Gut Microbiota in Subjects With ObesityNCT05200468 · lead sponsor · 2022-07-28
COMPLETED
Acute Effect of Low-intensity Gamma rTMS on Cognitive and EEG Parameters in Adults With Mild Dementia by Alzheimer's DiseaseNCT05784298 · lead sponsor · 2022-04-28
COMPLETED
Effect of Insulin Resistance on Branched Chain Amino Acid Metabolism.NCT04886973 · lead sponsor · 2022-03-31
COMPLETED
Prognostic Value of the Right Ventricular Function by Portable Ultrasound in Patients With Pulmonary Hypertension.NCT05343091 · lead sponsor · 2021-03-01
UNKNOWN
Camostat and Artemisia Annua vs Placebo in COVID-19 OutpatientsNCT04530617 · lead sponsor · 2020-10-05
TERMINATED
Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico.NCT04567979 · lead sponsor · 2020-06-11
COMPLETED
Continuous Glucose Monitorization in Hospitalized Patients With COVID-19NCT05096858 · lead sponsor · 2020-06-01
UNKNOWN
Impact on Glycemic Variability in Newly Onset T2DM Patients Initiating Dapagliflozin Plus Metformin Versus Metformin AloneNCT04090580 · lead sponsor · 2019-10-27
COMPLETED
Pyridostigmine as Immunomodulator in People Living With HIVNCT03312244 · lead sponsor · 2019-07-01
SUSPENDED
Effect of Dietary Protein and Energy Restriction in the Improvement of Insulin Resistance in Subjects With ObesityNCT03627104 · lead sponsor · 2018-09-03
COMPLETED
Glycemic Variability Comparing Two vs Five Meals in Type 2 DiabetesNCT04127994 · lead sponsor · 2018-08-17
COMPLETED
Effect of the SCL16A11 Risk Haplotype on Treatments to Prevent Type 2 DiabetesNCT05990205 · lead sponsor · 2018-04-17
COMPLETED
Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer PatientsNCT02670109 · lead sponsor · 2018-02-01
UNKNOWN
Effect of the CAIPaDi Care Model in Relatives of Patients With Type 2 Diabetes MellitusNCT03234946 · lead sponsor · 2017-06-19
UNKNOWN
Transcriptomics of Mononuclear Cells and Inflammatory Status of Obese Patients Treated With Omega-3 Fatty AcidsNCT05219890 · lead sponsor · 2017-01-16
WITHDRAWN
A Peer Support Program to Enhance Treatment Adherence in Patients With Type 2 DMNCT03294265 · lead sponsor · 2016-08-01
UNKNOWN
Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic NephropathyNCT02689778 · lead sponsor · 2016-03-01
COMPLETED
Effects of a Novel Physical Exercise Program in Patients With Cirrhosis (the LFN-exercise Protocol)NCT03932552 · lead sponsor · 2016-02-01
COMPLETED
Effect of Metadoxine on Oxidative Stress in Non-alcoholic Hepatic SteatosisNCT02051842 · lead sponsor · 2016-01-01
UNKNOWN
Sugar-sweetened Beverage Intake Substitution by Water to Prevent Overweight in Mexican ChildrenNCT03069274 · lead sponsor · 2015-10-05
COMPLETED
Peripheral Arterial Insufficiency Associated With HIV/AIDSNCT02264509 · lead sponsor · 2014-09-01
COMPLETED
Dietary Intervention Modifies Gut Microbiota in Type 2 Diabetes.NCT03421301 · lead sponsor · 2014-08-07
COMPLETED
Effect of Topic Pirfenidone in Diabetic UlcersNCT02222376 · lead sponsor · 2013-10-01
COMPLETED
Resveratrol Stimulates Insulin Sensitivity in Subjects With Obesity and Insulin ResistanceNCT06961279 · lead sponsor · 2013-09-15
COMPLETED
Genistein Stimulates Insulin Sensitivity Through Gut MicrobiotaNCT04105023 · lead sponsor · 2013-09-15
COMPLETED
Reduction in Consumption of Sweetened Beverages on Weight, Body Composition and Blood Pressure in Young AdultsNCT02347267 · lead sponsor · 2012-05-01
COMPLETED
Resistance Exercise Program and Branched Chain Amino Acid Supplementation in Heart Failure PatientsNCT02240511 · lead sponsor · 2011-08-01
COMPLETED
The Effects of a High Fat and Low Carbohydrate Diet on Clinical Status in Patients With Heart FailureNCT02150798 · lead sponsor · 2011-05-01
COMPLETED
R230C and C230C Variants of ABCA1 and Glyburide ResponseNCT01456650 · lead sponsor · 2011-03-01
COMPLETED
Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected PatientsNCT00988780 · lead sponsor · 2009-12-01
UNKNOWN
Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to DysinsulinismNCT00847080 · lead sponsor · 2008-12-01
COMPLETED
Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune ResponseNCT00518154 · lead sponsor · 2007-09-01
COMPLETED
Effect of Physical Training Program on Health-related Quality of Life in CirrhosisNCT00517738 · lead sponsor · 2007-02-01
COMPLETED
Omentectomy and Metabolic SyndromeNCT00923260 · lead sponsor · 2005-12-01
COMPLETED
PI Vs. NNRTI Based Therapy for HIV Advanced DiseaseNCT00162643 · lead sponsor · 2004-12-01
UNKNOWN
Long-Term Results of a Randomized Trial Comparing Banded-versus-Standard Laparoscopic Roux-en-Y Gastric BypassNCT01504685 · lead sponsor · 2003-05-01
COMPLETED
Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program.NCT06090747 · collaborator · 2023-03-09
RECRUITING
Genetic Bases of Neuroendocrine Neoplasms in Mexican PatientsNCT06523582 · collaborator · 2022-08-03
RECRUITING
CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational RegistryNCT07567378 · collaborator · 2026-05-01
NOT_YET_RECRUITING
PRuDENTE; Diabetes Prevention Via Exercise, Nutrition and TreatmentNCT03194009 · collaborator · 2017-08-10
UNKNOWN
Ultrasound Impact in Rheumatoid Arthritis Patient Reported OutcomesNCT03228342 · collaborator · 2017-05-03
COMPLETED
Effect of Whole-body Vibration on TcPO2NCT03957811 · collaborator · 2017-04-04
UNKNOWN
Metabolism Effects of Artificially Sweetened Beverages RestrictionNCT03679689 · collaborator · 2017-02-01
COMPLETED
Efficacy Study of Metformin Glycinate on Postprandial LipemiaNCT02064881 · collaborator · 2015-10-01
UNKNOWN
Metformin Plus Neoadjuvant Chemotherapy in Breast CancerNCT01566799 · collaborator · 2012-04-01
UNKNOWN
Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)NCT01875952 · collaborator · 2010-05-01
UNKNOWN

Sponsor roles

lead sponsor47
collaborator10

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.